ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,779, issued on Sept. 22, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).
"Kits" was invented by Joan Yesid Mendivil Medina (Cham, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of assessing the efficacy of a treatment regimen in a subject by measuring the concentration of one or more biomarkers associated with plasma kallikrein prior to the first dose of a polypeptide that binds plasma kallikrein. A treatment regimen is considered effective if the concentration of one or more biomarkers decreases after administration of the polypeptide."
The patent was filed on May 2, 2025, under Application N...